Zhongquan Qi

Anti-lymphocyte function-associated antigen-1 monoclonal antibody inhibits CD40 ligand-independent immune responses and prevents chronic vasculopathy in CD40 ligand-deficient mice. (2002)

Corbascio, Matthias, Mahanty, Harish, Osterholm, Cecilia, Qi, Zhongquan, Pearson, Thomas C, Larsen, Christian P, ...

BACKGROUND: Blockade of CD40 ligand (CD40L; CD154, gp39) is a potential treatment for autoimmune disease and allograft rejection. However, CD40L-/- mice are capable of mobilizing cellular immune...

CTLA4Ig combined with anti-LFA-1 prolongs cardiac allograft survival indefinitely. (2002)

Corbascio, Matthias, Ekstrand, Helene, Osterholm, Cecilia, Qi, Zhongquan, Simanaitis, Mecislovas, Larsen, Christian P, ...

CTLA4Ig and anti-LFA-1 are members of a new generation of immunomodulatory drugs which inhibit important signaling pathways in T cell activation. Both substances target molecules which have pivitol...

Inhibition of acute allogaft rejection - experimental transplant studies with biological and chemical immunosuppressants (1999)

Qi, Zhongquan

In clinical transplantation immunosuppressive agents are used in combination with the objective to achieve additive effects and less toxicity. A large number of novel drugs are candidates for...

Inhibition of acute allogaft rejection - experimental transplant studies with biological and chemical immunosuppressants (1999)

Qi, Zhongquan

In clinical transplantation immunosuppressive agents are used in combination with the objective to achieve additive effects and less toxicity. A large number of novel drugs are candidates for...